Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules

Human Immunology

Volumn 64, Issue 2, 2003, Pages 256-264

  Poláková, Katarina ^a   Bennink, Jack R ^c   Yewdell, Jonathan W ^c   Bystrická, Magdaléna ^b   Bandžuchová, Elena ^d   Russ, Gustáv ^b  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b INSTITUTE OF VIROLOGY   (Slovakia)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

Heavy chain; HLA class I; HLA G; Leukemia cell lines; mAb 4H84

Indexed keywords

ACID; HLA ANTIGEN CLASS 1; HLA G ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN DETECTION; ARTICLE; CONFORMATION; CONTROLLED STUDY; CROSS REACTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LEUKEMIA CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; BETA 2-MICROGLOBULIN; CHORIOCARCINOMA; CITRIC ACID; CROSS REACTIONS; EPITOPES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOBLOTTING; LEUKEMIA; PHOSPHATES; PROTEIN DENATURATION; PROTEIN ISOFORMS; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0037314076     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00777-2     Document Type: Article

References (31)

1. Loke YW, Hiby SE, King A: Human leukocyte antigen-G and reproduction. J Reprod Immunol 43:235, 1999.
2. Blaschitz A, Lenfant F, Mallet V, Hartmann M, Bensussan A, Geraghty DE, LeBouteiller P, Dohr G: Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 27:3380, 1997.
3. Schust DJ, Tortorella D, Ploegh H: HLA-G and HLA-C at the feto-maternal interface: lessons learned from pathogenic viruses. Semin Cancer Biol 9:37, 1998.
4. King A, Burrows TD, Hiby SE, Bowen JM, Joseph S, Verma S, Lim PB, Gardner L, LeBouteiller P, Ziegler A, Uchanska-Ziegler B, Loke YW: Surface expression of HLA-C antigen by human extravillous trophoblasr. Placenta 21:376, 2000.
5. Cabestre FA, Lefebvre S, Moreau P, Rouas-Friess N, Dausset J, Carosella ED, Paul P: HLA-G expression: immune privilege for tumour cells? Semin Cancer Biol 9:27, 1999.
6. O'Callaghan CA, Bell JI: Structure and function of the human class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev 163:129, 1998.
7. Wiend H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Bornemann A, Meyermann R, Weiss EH, Melms A, Weller M: A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 168:4772, 2002.
8. Amiot L, Onno M, Drenou B, Monvoisin C, Fauchet R: HLA-G class I gene expression in normal and malignant hematopoietic cells. Hum Immunol 59:524, 1998.
9. Real LM, Cabrera T, Canton J, Oliva R, Ruiz-Cabello F, Garrido F: Expression of HLA-G in tumors is not a frequent event. Int J Cancer 81:512, 1999.
10. Pangault C, Amiot L, Caulet-Maugendre S, Brasseur F, Guilloux V, Drenou B, Fauchet R, Onno M: HLA-G protein expression is not induced during malignant transformation. Tissue Antigens 53:335, 1999.
11. Frumento G, Franchello S, Palmisano GL, Nicotra MR, Giacomini P, Loke YW, Geraghty DE, Maio M, Manzo C, Natali PG, Ferrara GB: Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gamma IFN-γ treatment. Tissue Antigens 56:30, 2000.
12. Davies B, Hiby S, Gardner L, Loke YW, King A: HLA-G expression by tumors. Am J Reprod Immunol 45:103, 2001.
13. Paul P, Cabestre FA, LeGal FA, Khalil-Daher I, LeDanff C, Schmid M, Mercier S, Avril MF, Dausset J, Guillet JG, Carosella ED: Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res 59:1954, 1999.
14. Mizuno S, Emi N, Kasai M, Ishitani A, Saito H: Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia. Br J Haematol 111:280, 2000.
15. Wagner SN, Rebmann V, Willers CP, Grosse-Wilde H, Goos M: Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma. Lancet 356:220, 2000.
16. Urosevic M, Kurrer MO, Kamarashev J, Mueller B, Weder W, Burg G, Stahel RA, Dummer R, Trojan A: Human leukocyte antigen G up-regulation in lung cancer associates with high grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 159:817, 2001.
17. Urosevic M, Willers J, Mueller B, Kempf W, Burg G, Dummer R: HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 99:609, 2002.
18. Paul P, Rouas-Freiss N, Moreau P, Cabestre FA, Menier C, Khalil-Daher I, Pangault C, Onno M, Fauchet R, Martinez-Laso J, Morales P, Villena AA, Giacomini P, Natali PG, Frumento G, Ferrara GB, McMaster M, Fisher S, Schust D, Ferrone S, Dausset J, Geraghty D, Carosella ED: HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol 61:1177, 2000.
19. Polakova K, Karpatova M, Russ G: Dissociation of b2-microglobulin is responsible for selective reduction of HLA class I antigenicity following acid treatment of cells. Mol Immunol 30:1223, 1993.
20. Storkus WJ, Zeh III HJ, Salter RD, Lotze MT: Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid solution. J Immunotherapy 14:94, 1993.
21. Polakova K, Russ G: Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted. Neoplasma 47:342, 2000.
22. McMaster M, Zhou Y, Shorter S, Kapasi K, Geraghty D, Lim KH, Fisher S: HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J Immunol 160:5922, 1998.
23. Pearson WR, Lipman DJ: Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 85:2444, 1988.
24. Gillet AC, Perarnau B, Mercier P, Lemonnier FA: Serological analysis of the dissociation process of HLA-B and C class I molecules. Eur J Immunol 20:759, 1990.
25. Sernee MF, Ploegh HL, Schust DJ: Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents. Mol Immunol 35:177, 1998.
26. Moy FJ, Desai SA, Wang X, Noronha EJ, Zhou Q, Ferrone S, Powers R: Analysis by NMR spectroscopy of the structural homology between the linear and the cyclic peptide recognized by anti-human leukocyte antigen class I monoclonal antibody TP25.99. J Biol Chem 275:24679, 2000.
27. Desai SA, Wang X, Noronha EJ, Zhou Q, Rebmann V. Grosse-Wilde H, Moy FJ, Powers R, Ferrone S: Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on b2-microglobulin-associated and b2-microglobulin-free HLA class I heavy chains J Immunol 165:3275, 2000.
28. Bix M, Raulet D: Functionally conformed free class I heavy chains exist on the surface of b2 microglobulin negative cells. J Exp Med 176:829, 1992.
29. Schnabl E, Stockinger H, Majdic O, Gaugitsch H, Lindley IJD, Maurer D, Hajek-Rosenmayr A, Knapp W: Activated human T lymphocytes express MHC class I heavy chains not associated with β2-microglobulin. J Exp Med 171:1431, 1990.
30. Madrigal JA, Belich MP, Benjamin RJ, Little AM, Hilderbrand WH, Mann DL, Parham P: Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surface of activated B and T cells. J Exp Med 174:1085, 1991.
31. Marozzi A, Meneveri R, Bunone G, DeSantis C, Lopalco L, Berreta A, Agresti A, Siccardi AG, Della Valle G, Ginnelli E: Expression of beta 2m-free HLA class I heavy chains in neuroblastoma cell lines. Scand J Immunol 37:661, 1993.